EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Leveraging Microorganisms to Combat Skin Cancer

Hayden J Oyler iD, Austen W Callister, Makenzi N Kutch, Mark R Wakefield iD, Yujiang Fang

Microorganisms · 19.02.2025 · 13 (2) · 462

DOI: 10.3390/microorganisms13020462 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microorganisms, online erschienen am 19.02.2025. Verfasst von Hayden J Oyler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. Yujiang Fang.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin cancer, including melanoma and non-melanoma types, presents a significant and growing global health challenge due to its increasing incidence and mortality rates. While conventional treatments such as surgical excision, immunotherapy, and targeted therapies are well-established, microorganism-based approaches represent an innovative and promising alternative. These therapies employ live, genetically engineered, or commensal bacteria, viral vectors, or bacterial components to achieve various therapeutic mechanisms, including tumor targeting, immune system modulation, vascular disruption, competitive exclusion, drug delivery, and direct oncolysis. Despite their potential, these approaches require further investigation to address safety concerns, optimize treatment protocols, and gain a comprehensive understanding of their long-term outcomes.

Schlagwörter

Stichwörter der Autor:innen

microorganism cancer treatmentnanocarriersoncolytic virusesprobioticsskin cancer treatmentskin microbiota

Autor:innen und Institutionen

  • Department of Microbiology, Immunology & Pathology, Des Moines University, West Des Moines, IA 50266, USA.
  • Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84132, USA.
  • Department of Surgery, School of Medicine, University of Missouri, Columbia, MO 65211, USA.
  • Ellis Fischel Cancer Center, School of Medicine, University of Missouri, Columbia, MO 65211, USA.

ORCID-Profile: Hayden J Oyler, Mark R Wakefield

Förderung

  • Dr. Yujiang Fang

Zitieren

APA

Oyler, H. J., Callister, A. W., Kutch, M. N., Wakefield, M. R., & Fang, Y. (2025). Leveraging Microorganisms to Combat Skin Cancer. Microorganisms, 13(2), 462. https://doi.org/10.3390/microorganisms13020462

Vancouver

Oyler HJ, Callister AW, Kutch MN, Wakefield MR, Fang Y. Leveraging Microorganisms to Combat Skin Cancer. Microorganisms. 2025;13(2):462. doi:10.3390/microorganisms13020462

BibTeX
@article{Oyler2025,
  author = {Oyler, Hayden J and Callister, Austen W and Kutch, Makenzi N and Wakefield, Mark R and Fang, Yujiang},
  title = {Leveraging Microorganisms to Combat Skin Cancer},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {2},
  pages = {462},
  doi = {10.3390/microorganisms13020462}
}
Kostenlos starten →